Casomorphin
Template:Short description Template:Refimprove
Casomorphin is an opioid peptide (protein fragment) derived from the digestion of the milk protein casein.<ref name=EFSA/>
Health
Digestive enzymes can break casein down into peptides that have some biological activity in cells and in laboratory animals though conclusive causal effects on humans have not been established.<ref name=EFSA></ref>
Some practitioners of alternative medicine claim that casomorphin may cause some of the symptoms of autism, and promote casein exclusion diets as a supposed cure, Template:As of there was a lack of evidence that these diets had any effect.<ref>Template:Cite journal</ref>
If opioid peptides breach the intestinal barrier, typically linked to permeability and constrained biosynthesis of dipeptidyl peptidase-4 (DPP4), they can attach to opioid receptors. Elucidation requires a systemic framework that acknowledges that public-health effects of food-derived opioids are complex with varying genetic susceptibility and confounding factors, together with system-wide interactions and feedbacks.<ref name=pmid34360205>Template:Cite journal</ref>
List of known casomorphins (non-exhaustive)
β-Casomorphins 1–3
- Structure: Template:Mono
- Chemical formula: C23H27N3O5
- Molecular weight: 425.48 g/mol
Bovine β-casomorphins 1–4
- Structure: Template:Mono
- Chemical formula: C28H35N4O6
- Molecular weight: 522.61 g/mol
Bovine β-casomorphin 1–4, amide
{{#invoke:Labelled list hatnote|labelledList|Main article|Main articles|Main page|Main pages}}
- Structure: Template:Mono-NH2
- Chemical formula: C28H35N5O5
- Molecular weight: 521.6 g/mol
Bovine β-casomorphin 5
- Structure: Template:Mono
- Chemical formula: C30H37N5O7
- Molecular weight: 594.66 g/mol
Bovine β-casomorphin 7
- Structure: Template:Mono
- Chemical formula: C41H55N7O9
- Molecular weight: 789.9 g/mol
bBCM7 is produced in when digesting bovine A1 beta-casein outside of the body using pancreatic enzymes, and inside of some animal bodies. The A2 form, which follows Ile with a Pro instead of a His, is more resistant to the release of bBCM7, presumably because the proline residue blocks the action of a carboxyl peptidase. bBCM7 has significant opioid effects when injected (and in more recent research, orally fed) into animals,<ref name=pmid34360205/> but human studies supporting the use of "bBCM7-free" A2 milk is still lacking.<ref name=EFSA>Template:Cite journal</ref>
Human β-casomorphin 7
- Structure: Template:Mono
Despite human beta-casein having a A2-like "P" after "I", human colostrum and early lactation-stage milk contains significant amounts of hBCM7. It is a much weaker opioid and the FVQ sequence renders it susceptible to further degradation.<ref name=pmid34360205/>
Bovine β-casomorphin 8
- Structure: Template:Mono
- Chemical formula (A2): C46H62N8O10
- Molecular weight (A2): 887.00 g/mol
X is H (histidine) in A1 and P (proline) in A2.
Bovine β-casomorphin 9
- Structure: Template:Mono
X is H (histidine) in A1 and P (proline) in A2.
Produced from both A1 and A2. Opioid agonist, but apparently without the detrimental effect of bBCM7 in cell cultures and animal models, and in fact considered potentially beneficial.<ref name=pmid34360205/>
Other bioactive casein-derived peptides
- Template:Mono is beneficial to mice.<ref>Template:Cite journal</ref><ref>Template:Cite journal</ref>